Sounds like a distraction to me. They're supposed to be focused on the high margin side of things, and this ain't it. I'd surely suspect that the take-up and prescription of these products would be multiples lower than that of cannabis so I see the upside.
At least the loan is on good terms so they're generating income from some of that cash.
Ann: Psychedelic joint venture with PharmAla Biotech, page-4
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add VIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.015(14.3%) |
Mkt cap ! $69.10M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 12.0¢ | 10.0¢ | $87.66K | 796.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 88095 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 23159 | 2 |
View Market Depth
| Last trade - 15.59pm 18/10/2024 (20 minute delay) ? |
| VIT (ASX) Chart |